
Apollo Hospitals reported a 34% rise in Q1FY27 net profit, reaching ₹581 crore. This growth surpassed estimates, driven by high-complexity specialty volumes and a 21% increase in revenue to ₹7,043 crore. The company's strong performance highlights its robust pharmacy growth and specialty services, positioning it well in the healthcare market.
⚖️ AI Verdict
"Looks like Apollo Hospitals is on a winning streak!"
Ask about this Intel File
File Opened for Analysis
Ask me anything about the event, its implications, or who is responsible for the SINS!
Deepen Investigation
Buying a co-owner's share in property complicates capital gains tax. This article explains how different acquisition dates and costs impact tax calculations when selling the entire asset.
Learn about child certificates under the Income Tax Act 2025. These certificates help taxpayers secure lower or nil TDS/TCS rates. Discover who needs them and the easy steps to generate one, ensuring you maximize your tax benefits.
Zerodha Fund House has introduced an arbitrage fund designed for short-term cash management. With a minimum investment of ₹5,000, this fund targets investors seeking lower volatility compared to traditional equity funds. Ideal for those looking to optimize surplus cash, the new offering promises a strategic approach to short-term investments.
Jyothy Labs' operating margin has plummeted to 8.4% due to the West Asia crisis and Henkel AG's exit from their licensing deal. The company's margin dropped significantly from 16.5% last year, despite a price hike of 4-4.5% in the June quarter. This downturn highlights the challenges faced by Jyothy Labs in maintaining profitability amidst external pressures.